Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: Modulation of NF- κB and AP-1 transcription factors activity

Blood

Volumn 88, Issue 9, 1996, Pages 3482-3490

  Muñoz, Cecilia ^b   Pascual Salcedo, Dora ^b   Castellanos, María Del Carmen ^b   Alfranca, Arántzazu ^b   Aragonés, Julián ^b   Vara, Alicia ^b   Redondo, Juan Miguel ^b   De Landázuri, Manuel O ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BACTERIUM LIPOPOLYSACCHARIDE; DITHIOCARBAMIC ACID DERIVATIVE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PYRROLIDINE DERIVATIVE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029959753     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3482.bloodjournal8893482     Document Type: Article

References (48)

1. Mantovani A, Bussolino F, Dejana E: Cytokine regulation of endothelial cell function. FASEB J 6:2591, 1992
2. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 7:2068, 1994
3. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6:865, 1994
4. Wang JM, Colella S, Allavena P, Mantovani A: Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology 60:439, 1987
5. Socinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L, Griffins JD: Granulocyte-macrophage colony-stimulating factor induces the expression of the CDI 1b surface adhesion molecule on human granulocytes in vivo. Blood 72:691, 1988
6. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: Vascular adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866, 1993
7. Weber C, Erl W, Pietsch A, Ströbel M, Lörns Ziegler-Heitbrock HW, Weber PC: Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular adhesion molecule-1 in human endothelial cells stimulated to generate radicals. Arterioscler Thromb 14:1665, 1994
8. Orthner CL, Rodgers GM, Fitgerald LA: Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: Evidence implicating nuclear factor-κB in TF induction by diverse agonists. Blood 86:436, 1995
9. Staal FTJ, Anderson MT, Staal GEJ, Herzenberg LA, Gitler C, Herzenberg LA: Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci USA 91:3619, 1994
10. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141, 1994
11. Scherck R, Meier B. Männel DN, Dröge W, Baeuerle P: Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 175:1181, 1992
12. Abate C, Patel L, Rauscher FJ III, Curran T: Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249:1157, 1990
13. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:2005, 1993
14. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K: Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 10:561, 1990
15. Zhang Y, Lin J-X, Vilcek J: Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence. Mol Cell Biol 10:3818, 1990
16. Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 10:2327, 1990
17. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265:21128, 1990
18. Stein B, Baldwin AS: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol 13:7191, 1993
19. Schreck R, Baeuerle PA: NF-κB as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor. Mol Cell Biol 10:1281, 1990
20. Helle M, Boeije L, De Groot E, De Vos A, Aarden L: Sensitive ELISA for interleukin-6. J Immunol Meth 138:47, 1991
21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
22. Sambroock J, Fritsch EF, Maniatis T: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989.
23. Osborn L, Kunkel S, Nabel GJ: Tumor necrosis factor α and interleukin 1 stimulate the immunodeficiency virus enhancer by active nuclear factor κB. Proc Natl Acad Sci USA 86:2336, 1989
24. Redondo JM, Pfhol JL, Krangel MS: Identification of an essential site for transcriptional activation within the human T-cell receptor δ enhancer. Mol Cell Biol 11:5671, 1991
25. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 54:1, 1993
26. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 36:559, 1994
27. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K: Novel mechanism of glucocorticoid-mediated gene repression. J Biol Chem 269:13289, 1994
28. Oliveira IC, Mukaida N, Matsushima K, Vilcek J: Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol Cell Biol 14:5300, 1994
29. Okamoto S, Mukaida N, Yasumoto K, Rice N, Ishikawa Y, Horiguchi H, Murakami S, Matsushima K: The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 269:8582, 1994
30. Stein B, Yang MX: Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 15:4971, 1995
31. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10197, 1993
32. Tsuboi A, Muramatsu A, Tsutsumi A, Arai K, Arai N: Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-κB/AP-1 in T cells. Biochem Biophys Res Commun 199:1064, 1994
33. Himes SR, Coles LS, Katsikeros, Lang RK, Shannon MF: HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kappa B with other transcription factor families. Oncogene 8:3189, 1993
34. Wang CY, Bassuk AG, Boise LH, Thompson CB, Bravo R, Leiden JM: Activation of the granuloyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol Cell Biol 14:1153, 1994
35. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129, 1991
36. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483, 1995
37. Fauci AS, Pantaleo G: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 13:487, 1995
38. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, Dietrich M, German DTC study group: Inhibition of HIV progression by dithiocarb. Lancet 335:679, 1990
39. Praenckner EB, Wilk S, Baeuerle PA: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13:5433, 1994
40. Praenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA: Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14:2876, 1995
41. Miyamato S, Maki M, Schmitt MJ, Hatanaka M, Verma IM: Tumor necrosis factor α-induced phosphorylation of IκB-α is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 91:12740, 1994
42. Finco TS, Beg AA, Baldwin AS: Inducible phosphorylation of IκB-α is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 91:11884, 1994
43. Chen CC, Rosenbloom CI, Anderson DC, Manning AM: Selective inhibition of E-selectin, vascular cell adhesion molecule-1, an intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation. J Immunol 155:3538, 1995
44. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T: The proteasome pathway is required for cytokine-induced endothelial leukocyte adhesion molecule expression. Immunity 2:493, 1995
45. Löms Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky, Weber C, Wedel A, Schreck R, Baeuerle P, Ströbel M: Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 12:6986, 1993
46. Suzuki YJ, Mitzuno M, Packer L: Signal transduction for nuclear factor-κB activation. J Immunol 153:5008, 1994
47. Li Y, Jaiswal AK: Regulation of human NAD(P)H:quinone oxidoreductase gene. J Biol Chem 267:15097, 1992
48. Hsu W, Kerppola TK, Chen P, Curran T, Chen-Kiang S: Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol Cell Biol 14:268, 1994